Landmark Avandia Settlement Won’t Protect Patients

Recently, Pfizer paid a $2 billion fine and GlaxoSmithKline coughed up $3 billion in fines for failing to report safety data about the diabetes drug, Avandia. Yet the costly Avandia settlement doesn’t seem to have changed the way pharmaceuticals are marketed. The only way to stop pharmaceutical companies from continuing to market and sell drugs …

Landmark Avandia Settlement Won’t Protect Patients Read More »